TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Inro Biomedtek AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 398 | 368 | 362 |
Financial expenses | 7,802 | 4 | 462 |
Earnings before taxes | -7,375 | 3,479 | 19,072 |
EBITDA | 315 | 280 | 192 |
Total assets | 14,619 | 23,749 | 57,133 |
Current assets | 14,422 | 23,497 | 48,781 |
Current liabilities | 1,309 | 1,739 | 38,038 |
Equity capital | 13,310 | 21,117 | 18,373 |
- share capital | 100 | 100 | 100 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 91.0% | 88.9% | 32.2% |
Turnover per employee | 398 | 368 | 362 |
Profit as a percentage of turnover | -1853.0% | 945.4% | 5268.5% |
Return on assets (ROA) | 2.9% | 14.7% | 34.2% |
Current ratio | 1101.8% | 1351.2% | 128.2% |
Return on equity (ROE) | -55.4% | 16.5% | 103.8% |
Change turnover | 30 | 6 | -150 |
Change turnover % | 8% | 2% | -29% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.